30Oct
29Oct
EcoSoul Secures Walmart Deal, Expands Series A+ Funding
As a reminder, EcoSoul is a leading omnichannel brand of sustainable dinnerware and home essentials co-founded by former Wayfair executives. The company has agreed to allow SCP LPs the opportunity to invest additional capital at the previous rounds' terms ($90M pre-money valuation with 25% discount). This follows SCP's prior investments in EcoSoul's $9M Series A round in September 2022 at a $54M pre-money valuation. EcoSoul has an additional 25,000 stores in their pipeline across the US, UK, Canada, India, and...
25Oct
Insulation company to build 60,000-square-foot production facility in Chehalis
In an announcement Tuesday, the U.S. Department of Energy (DOE) announced that CleanFiber will receive two $10 million federal grants to build facilities in Chehalis and Ennis, Texas, that will create 80 full-time jobs. The Chehalis plant is one of 14 projects announced by DOE to increase clean energy manufacturing in 15 coal communities across the United States. CleanFiber will conduct outreach to disadvantaged and displaced coal workers and has pledged to remain neutral during any union-organizing campaigns. According to...
24Oct
23 Best Wine Gifts for 2024: From Bottles to Barware
A bottle of wine is an easy go-to gift for any wine lover. But if you want to take it up a notch, we’ve put together the best gifts for wine enthusiasts -- from budget-friendly to totally bougie -- that are sure to impress. Best wine gifts under $25, Archer Roose Explorer Pack of Wine (12 cans) - Canned drinks are all the rage, and for those who want an easy way to take wine on the go -- whether...
23Oct
Boston Harbor Angels Captain’s Dinner: Gufo!
After an enjoyable dinner at Vela, the BHA Captain's Dinner made its way to Gufo, an Italian restaurant located in East Cambridge known for its tasty pizzas and ambiance. The staff at Gufo welcomed the group warmly, and the BHA attendees experienced the restaurant's jovial and warm atmosphere. The food was delicious and unique! Their dinner included many elaborate pizzas along with the appetizers such as white anchovies with aleppo and fennel pollen as well as the prosciutto with nectarine and...
23Oct
Eight nanotechnology companies to watch out for
Nanotechnology, which is the manipulation of molecules on an atomic scale, has been implemented by companies in medicine, with numerous applications in drug discovery, tissue engineering, imaging, and diagnostics. As techniques and tools to exploit nanotechnology in the field of healthcare progress, here are eight nanotechnology companies that you should know about. Zylo Therapeutics - Specializing in drug delivery, American biotech Zylo Therapeutics has created Z-pods, which are amorphous silica particles that have been engineered to encapsulate compounds, and can...
18Oct
Immusoft Reports Promising Early Data for Lead Candidate in MPS I
Nearly a year after making cell therapy history by dosing the first patient with the first engineered B cell in a human trial, Immusoft has reported promising but early clinical data showing its lead candidate was effective nine months after dosing, as well as safe. Immusoft has presented data from its Phase I trial (NCT05682144) assessing ISP-001 nine months after administering a single low dose of 2.5 x 107 cells/kg in a patient with mucopolysaccharidosis type I (MPS I). The...
17Oct
1908 Brands, Conscious Alliance send cleaning supplies to hurricane zones through Convoy of Hope
Boulder-born, green household cleaning product maker 1908 Brands Inc. and The Conscious Alliance Inc., which harnesses the power of musicians, artists and natural-foods companies to raise awareness and funds for food-accessibility projects say they have sent five truckloads of products to communities damaged by the recent Hurricanes Milton and Helene. The products will be donated to Convoy of Hope, who works with the Federal Emergency Management Agency and local municipalities to distribute supplies. “As we watch what is unfolding in...
17Oct
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, announced today that it has completed enrollment of the dose escalation part of its bridging Phase 1 clinical trial of CRB-701 (SYS6002). The dose escalation part of this open label study (NCT06265727) is being conducted in the US and the UK. The three-part Phase 1 trial is evaluating the safety, pharmacokinetics and efficacy of CRB-701 in patients with advanced solid tumors...
15Oct